TSS
OMIC

Two Sigma Securities’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

Two Sigma Securities’s Portfolio OMIC Stock Details OMIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-419
Closed -$5.78K – 3823
2023
Q4 		$5.78K Buy
+419
New +$4.96K ﹤0.01% 2872

Other funds holding OMIC

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
QM
QVIDTVM Management The Woodlands, Texas $81.4M AUM 2.94% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Two Sigma Securities's OMIC Position: Q1 2024 in Review

Two Sigma Securities sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q1 2024, closing a stake of 419 shares — an estimated $5.78K sold.

Two Sigma Securities first reported a position in OMIC in Q4 2023 and held it in 1 quarter. The position peaked at $5.78K in Q4 2023. 42 funds tracked by Wall St. Rank hold OMIC as of Q1 2024.

  • Two Sigma Securities reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Two Sigma Securities sold 419 Singular Genomics Systems, Inc. Common Stock shares in Q1 2024, an estimated $5.78K.
  • Two Sigma Securities first reported a position in Singular Genomics Systems, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
  • Two Sigma Securities's Singular Genomics Systems, Inc. Common Stock position peaked at $5.78K in Q4 2023.
  • 42 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q1 2024.

Based on Two Sigma Securities's 13F filing for Q1 2024, filed 15 May 2024.